Miss Laila Shah BSc, MSc

 

Research Administrator

Contact details

Telephone +44 (0)121 415 9107

Fax +44 (0)121 415 9136

Email l.shah@bham.ac.uk

Birmingham Clinical Trials Unit
School of Cancer Sciences
Robert Aitken Institute

About

Laila Shah is a member of the systematic review team who assists in undertaking systematic reviews in disease areas such as; Parkinson’s disease and other neurological disorders. The post involves identification and retrieval of relevant publications from the literature and the extraction and collection of data for analysis.

Her other responsibilities include literature management; literature searching using various computer based bibliographic databases; managing the BCTU publication database & maintaining the unit’s publication electronic database, paper archive, staff members’ publications & producing annual and ad hoc reports on total and individual publications; providing support to the other systematic reviewers and members of the unit as required.

Qualifications

  • BSc (Hons) Combined Health Studies, Birmingham City University 1996
  • MSc Health Care Ethics, University of Birmingham 1997

Biography

Laila qualified with a Bachelors degree in Combined Health Studies in 1996 from Birmingham City University. The degree included 3 subject areas e.g. Physiology, Sociology & Psychology. She went on to study for her Masters in Health Care Ethics in 1997 at the University of Birmingham. Following her Masters she had various temping positions. In 2001 she began working as a temporary Research Assistant at BCTU and then applied for her current position as a Research Administrator in 2002 in the Systematic Review Team.

Research

Research Areas

Parkinson Disease, Migraine, Systematic Reviews, Clinical Trials.

Research Activity

Parkinson’s Disease (PD)
Main research activity areas within PD are: Medical therapy, rehabilitation and surgery. Recent work has included assisting in literature searches to update two Cochrane systematic reviews assessing the effectiveness of physiotherapy intervention vs. no intervention in patients with PD and the comparison physiotherapy techniques; meta-analysis of randomised trials assessing the efficacy of neurosurgery in patients with advanced PD.

Publications

Gray R, Hills R, Shah L, Stowe R. (2005), Aromatase inhibitors (AI) versus tamoxifen for ER-positive breast cancer - a meta-analysis. European Journal of Cancer;3:35-36.

Gray R, Hills R, Shah L, Stowe R, Davies C. (2006), Anti-estrogens for early breast cancer - tamoxifen or aromatase inhibitor (AI) and for how long? 10-year update on ATLAS/aTTom. Endocrine Treatment & Prevention of Breast and Gynaecological Cancers;128-129.

Ives NJ, Stowe RL, Clarke CE, Gray R, Wheatley K, Shah L. (2004), Dopamine agonist therapy in early Parkinson's disease: A systematic review of randomised controlled trials. Movement Disorders;19(Suppl 9):586.

Ives NJ, Stowe RL, Clarke CE, Shah L, Hawker RJ, Gray R, Wheatley K. (2004), Meta-analysis of dopamine agonist trials in early Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry;75(5):071.

Ives NJ, Stowe RL, Clarke CE, Shah L, Hawker RJ, Gray R, Wheatley K. (2003), Meta-analysis of dopamine agonist trials in early Parkinson’s disease. Proceedings from the 8th National Conference – Multidisciplinary Care in Parkinson’s disease and Parkinsonism from Science to Practice. Book of Abstracts.

Ives NJ, Stowe RL, Shah L, Hawker RJ, Clarke CE, Gray RG, Wheatley K. (2003), Meta-analysis of 5038 patients in 28 randomized trials comparing dopamine agonists with levodopa. Alzheimer's and Parkinson's Disease: New Perspectives. 6th International Conference AD/PD;119-119.

Stowe RL, Ives NJ, Clarke C, van Hilten JJ, Ferreira J, Hawker RJ, Shah L, Wheatley K, Gray R. (2008), Dopamine agonist therapy in early Parkinson's disease. Cochrane Database of Systematic Reviews (2):CD006564.

Back to top